These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 37531904

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ginsenoside Ro Ameliorates High-Fat Diet-Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein-Coupled Bile Acid Receptor 5 Pathway.
    Jiang LS, Li W, Zhuang TX, Yu JJ, Sun S, Ju ZC, Wang ZT, Ding LL, Yang L.
    J Pharmacol Exp Ther; 2021 Jun; 377(3):441-451. PubMed ID: 33820830
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Shengmai San formula alleviates high-fat diet-induced obesity in mice through gut microbiota-derived bile acid promotion of M2 macrophage polarization and thermogenesis.
    Wang Z, Wang X, Fu L, Xu S, Wang X, Liao Q, Zhuang T, Liu L, Zhang H, Li W, Xiong A, Gu L, Wang Z, Wang R, Tao F, Yang L, Ding L.
    Phytomedicine; 2024 Oct; 133():155938. PubMed ID: 39163753
    [Abstract] [Full Text] [Related]

  • 5. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P, Liu H, Boehme S, Xie C, Krausz KW, Gonzalez F, Chiang JYL.
    J Biol Chem; 2017 Jun 30; 292(26):11055-11069. PubMed ID: 28478385
    [Abstract] [Full Text] [Related]

  • 6. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
    Albaugh VL, Banan B, Antoun J, Xiong Y, Guo Y, Ping J, Alikhan M, Clements BA, Abumrad NN, Flynn CR.
    Gastroenterology; 2019 Mar 30; 156(4):1041-1051.e4. PubMed ID: 30445014
    [Abstract] [Full Text] [Related]

  • 7. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JYL.
    Hepatology; 2018 Oct 30; 68(4):1574-1588. PubMed ID: 29486523
    [Abstract] [Full Text] [Related]

  • 8. Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.
    Zhai H, Li Z, Peng M, Huang Z, Qin T, Chen L, Li H, Zhang H, Zhang W, Xu G.
    EBioMedicine; 2018 Jun 30; 32():201-214. PubMed ID: 29859856
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice.
    Selwyn FP, Csanaky IL, Zhang Y, Klaassen CD.
    Drug Metab Dispos; 2015 Oct 30; 43(10):1544-56. PubMed ID: 26199423
    [Abstract] [Full Text] [Related]

  • 11. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J, Clerbaux LA, Nachit M, Sempoux C, Staels B, Bindels LB, Tailleux A, Leclercq IA.
    JHEP Rep; 2022 Jan 30; 4(1):100387. PubMed ID: 34825156
    [Abstract] [Full Text] [Related]

  • 12. Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.
    Kuhre RE, Wewer Albrechtsen NJ, Larsen O, Jepsen SL, Balk-Møller E, Andersen DB, Deacon CF, Schoonjans K, Reimann F, Gribble FM, Albrechtsen R, Hartmann B, Rosenkilde MM, Holst JJ.
    Mol Metab; 2018 May 30; 11():84-95. PubMed ID: 29656109
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Study on the mechanism of modified Gegen Qinlian decoction in regulating the intestinal flora-bile acid-TGR5 axis for the treatment of type 2 diabetes mellitus based on macro genome sequencing and targeted metabonomics integration.
    Liu R, Wang J, Zhao Y, Zhou Q, Yang X, Gao Y, Li Q, Bai M, Liu J, Liang Y, Zhu X.
    Phytomedicine; 2024 Sep 30; 132():155329. PubMed ID: 38853123
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
    Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin SI, Perino A, Brighton CA, Sebti Y, Kluza J, Briand O, Dehondt H, Vallez E, Dorchies E, Baud G, Spinelli V, Hennuyer N, Caron S, Bantubungi K, Caiazzo R, Reimann F, Marchetti P, Lefebvre P, Bäckhed F, Gribble FM, Schoonjans K, Pattou F, Tailleux A, Staels B, Lestavel S.
    Nat Commun; 2015 Jul 02; 6():7629. PubMed ID: 26134028
    [Abstract] [Full Text] [Related]

  • 18. Gut microbiota-bile acids-glucagon like peptide-1 axis contributes the resistance to high fat diet-induced obesity in mice.
    Chen C, Liu L, Zhong Y, Wang M, Ai Y, Hou Y, Chen H, Lin X, Zhang Y, Ding M, Luo T, Li J, Li X, Xiao X.
    J Nutr Biochem; 2023 Jul 02; 117():109358. PubMed ID: 37085058
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypothalamic bile acid-TGR5 signaling protects from obesity.
    Castellanos-Jankiewicz A, Guzmán-Quevedo O, Fénelon VS, Zizzari P, Quarta C, Bellocchio L, Tailleux A, Charton J, Fernandois D, Henricsson M, Piveteau C, Simon V, Allard C, Quemener S, Guinot V, Hennuyer N, Perino A, Duveau A, Maitre M, Leste-Lasserre T, Clark S, Dupuy N, Cannich A, Gonzales D, Deprez B, Mithieux G, Dombrowicz D, Bäckhed F, Prevot V, Marsicano G, Staels B, Schoonjans K, Cota D.
    Cell Metab; 2021 Jul 06; 33(7):1483-1492.e10. PubMed ID: 33887197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.